GTC BIOTHERAPEUTICS INC (GTCB) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 209 transactions totaling $16.3M, demonstrating a bullish sentiment with $16.2M in net insider flow. The most recent transaction on Sep 30, 2010 involved a transaction of 4,688 shares valued at $1.5K.
No significant insider buying has been recorded for GTCB in the recent period.
No significant insider selling has been recorded for GTCB in the recent period.
Based on recent SEC filings, insider sentiment for GTCB is bullish with an Insider Alignment Score of 100/100 and a net flow of $16.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at GTC BIOTHERAPEUTICS INC (GTCB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading GTCB stock, having executed 209 transactions in the past 90 days. The most active insider is Biotechnologies S.a.s.u. Lfb (Executive), who has made 8 transactions totaling $48.1M.
Get notified when executives and directors at GTCB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 30, 2010 | W. Tuck Alan | Executive | Award | 4,688 | $0.32 | $1.5K | |
| Sep 30, 2010 | J. Bullock Francis | Executive | Award | 5,859 | $0.32 | $1.9K | |
| Jul 2, 2010 | J. Bullock Francis | Executive | Award | 4,076 | $0.46 | $1.9K | |
| Jul 2, 2010 | W. Mcnamara Pamela | Executive | Award | 2,174 | $0.46 | $1.0K | |
| Jul 2, 2010 | W. Tuck Alan | Executive | Award | 3,261 | $0.46 | $1.5K | |
| Apr 1, 2010 | W. Mcnamara Pamela | Executive | Award | 1,818 | $0.55 | $1000 | |
| Apr 1, 2010 | W. Tuck Alan | Executive | Award | 2,727 | $0.55 | $1.5K | |
| Apr 1, 2010 | J. Bullock Francis | Executive | Award | 3,409 | $0.55 | $1.9K | |
| Feb 9, 2010 | A. Scotland Richard | Executive | Purchase | 14,798 | $1.08 | $16.0K | |
| Jan 19, 2010 | A. Scotland Richard | Executive | Sale | 14,798 | $1.13 | $16.7K | |
| Jan 6, 2010 | S.a.s.u. Lfb Biotechnologies | Executive | Conversion | 2,281,368 | $2.63 | $6.0M | Large |
| Jan 6, 2010 | S.a.s.u. Lfb Biotechnologies | Executive | Conversion | 3,017,703 | $2.24 | $6.8M | Large |
| Dec 31, 2009 | W. Tuck Alan | Executive | Award | 2,000 | $0.75 | $1.5K | |
| Dec 31, 2009 | A. Geraghty James | Executive | Award | 4,000 | $0.75 | $3.0K | |
| Dec 31, 2009 | W. Mcnamara Pamela | Executive | Award | 1,333 | $0.75 | $1000 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 6 | $38.3M | 69.5% |
Purchase(P) | 40 | $16.2M | 29.5% |
Award(A) | 125 | $386.6K | 0.7% |
Sale(S) | 7 | $67.8K | 0.1% |
Payment(F) | 11 | $58.6K | 0.1% |
Other(J) | 16 | $17.3K | 0.0% |
Gift(G) | 4 | $0 | 0.0% |
Insiders at GTC BIOTHERAPEUTICS INC are accumulating shares at an accelerated pace. With 14 insiders making 209 transactions totaling $16.2M in purchases versus $67.8K in sales, the net buying activity of $16.2M signals strong executive confidence. Biotechnologies S.a.s.u. Lfb (Executive) leads the buying activity with $48.1M in transactions across all time.